MRI-AI model may help distinguish Parkinson’s, atypical parkinsonism
Neuropacs‘ MRI-based artificial intelligence (AI) technology demonstrated 96% accuracy in distinguishing Parkinson’s disease from atypical parkinsonism — including…
Articles by Andrea Lobo
Parkinson Italia backs initiative focusing on Parkinson’s prevention
Parkinson Italia — a network of 30 associations for patients and caregivers in Italy — is backing an initiative…
Multiple sleep difficulties common in people with early Parkinson’s
Most people with early-stage Parkinson’s disease have sleep disturbances, with many having more than one at the same time,…
Home care agency named Parkinson’s community care partner
Angels on Call, a home care services provider, has been recognized as a Community Partner in Parkinson’s Care…
Funding secured for environmental toxins project in Parkinson’s
A researcher at the University of Wollongong in Australia has received funding of nearly 400,000 Australian dollars (about $250,000) to…
Blood test may predict dementia risk in people with REM sleep disorder
Among people with rapid eye movement (REM) sleep behavior disorder, blood biomarkers associated with dementia may help identify those at…
First patient dosed in Parkinson’s clinical trial of Ventus’ VENT-02
A Phase 2a clinical trial testing Ventus Therapeutics’ VENT-02 — a novel brain-penetrating oral medication — in adults with mild…
FDA lists platform using rhythm to aid walking as Class II device
Note: This story was updated March 13, 2025, to correct that the company’s proprietary software is not available as a…
StrivePD Guardian launched to better personalized Parkinson’s care
Rune Labs has launched StrivePD Guardian, a personalized care delivery service to help Parkinson’s disease patients manage…
Onward Medical using 2 grants to test spinal stimulation device
Onward Medical has received two grants totaling about $2.5 million to support early feasibility studies assessing whether its implantable…